Toggle navigation
Home
Topics
Topics
Clinical Systems
Clinical Systems
Clinical Systems
Clinical Systems
Disinfection and Decontamination Products
Obstetrics and Gynecology
Obstetrics and Gynecology
Oncology Systems
Specialties
Specialties
Specialties
Specialties
Sports Medicine
Transformation
Transformation
Transformation
Transformation
Ultrasound Devices
Wearable Devices
CXO Insights
Vendor Viewpoint
News
Conferences
Newsletter
CXO Awards
About Us
US
US
EUROPE
APAC
Toggle navigation
Patient Monitoring Devices
Endoscopy
Dermatology Care
Medical Imaging Systems
Dental Care Devices
Sanitization Products and Equipment
Patient Monitoring Devices Latam
Orthopedic Devices and instruments Latam
Neurology Devices Latam
In Vitro Diagnostics Latam
Endoscopy Latam
Dental Care Devies Latam
Cardio Vascular Devices Latam
ENT Devices
Obstetrics and Gynecology
ENT Devices
Regenerative Medicine
Medical Equipment
Medical Imaging Systems
Patient Monitoring Devices
Regenerative Medicine
Cancer Care
Medical Equipment
Medical Device Design and Development
Medical Device Regulatory and Compliance
FemTech
Medical Device Design and Development Latam
Specialties
Transformation
Clinical Systems
Medical Aesthetics
Clinical Systems Latam
Specialties Latam
Clinical Systems
Specialties
Transformation Latam
Transformation
Medical Device Packaging
Transformation
Nephrology and Urology
Specialties
Clinical Systems
Wearable Devices
Vein Detection
Respiratory Care
Medical Device Design and Development
Neurology Devices
Disinfection and Decontamination Products
Endoscopy
Medical Equipment
Obstetrics and Gynecology
Surgical Devices and Instruments
Sports Medicine
Drug Delivery Solutions
Cardiovascular Devices
In Vitro Diagnostics
Medical Aesthetics
Patient Monitoring Devices
Dermatology Care
ENT Devices
Ultrasound Devices
Physiotherapy and Pain Management
Orthopedic Devices and Instruments
Biomechanics
Mobility Devices and Aids
Oncology Systems
Chronic and Long-Term Care
Dental Care Devices
Orthopedic Devices and instruments
In Vitro Diagnostic
Mobility Devices and Aids
Surgical Devices and Instruments
Drug Delivery Solutions
Physiotherapy and Pain Management
Medtech Startups
Cardio Vascular Devices
Surgical Devices and Instruments
Cardiovascular Devices
Physiotherapy and Pain Management
Drug Delivery Solutions
Medical Device Consulting
Orthopedic
Respiratory Devices
Medical Device Design and Development
Endoscopy
Medical Imaging Systems
In Vitro Diagnostics
Infection Control Solutions Canada
Physiotherapy and Pain Management Latam
Surgical Devices Latam
Medical Equipment
Regenerative Medicine
Cancer Care
Medical Equipment
Patient Monitoring Devices
Wearable Devices
Regenerative Medicine
MORE
NOVEMBER - 202119TRT together with a treating therapist, with the help of the information in the app and the cloud, can analyze and decipher the causes of worsening symptoms. This is an important prerequisite for being able to understand and manage the symptoms. "Our device can be used at work, leisure, or during sleep. This has been possible owing to the bone conduction technology that we use," says Mr. Westman.Duearity started its pre-marketing earlier this year with the aim of testing messages, images, and channels in communication with people suffering from tinnitus. "The response has been overwhelming and confirms that we are on the right track. Many people with tinnitus want to try our Tinearity. And the response from audiologists and therapists have been really good; they think our device is great for those who want treatment and relief," states Mr. Arndt.Further, they have also given positive responses about Duearity's Tinearity-AI. "We have learned lessons from communication, so now we know how to conduct marketing communication in a very efficient way as we approach the sharp launch of Tinearity in early 2022," says Mr. Westman. Duearity will initially sell directly to customers in Europe via its e-commerce platform. "Through communication and advertising in digital media, we will first market Tinearity and then Tinearitiy-AI in 2023/24," he mentions.The Road AheadDuearity also intends to enter the North American market in 2022. That's why they are currently searching for partners. "We have been considering collaboration opportunities with prospective partners for some time and it looks very bright with regard to the American market--which for various reasons can be very important," says Mr. Westman.He further mentions that Duearity has good opportunities globally, as the pre-marketing campaign has received a good response in several different regions, especially in Europe, North America, and Asia. "We are in the final stages of our proof of concept for Tinearity-AI. This will be completed in September this year. The most important thing is probably that we are convinced that the company will have a cash flow from the start of sales of Tinearity in 2022," concludes Mr. Arndt. Duearity addresses a large but forgotten market, namely tinnitus, with innovative products and services. We estimate that the market consists of at least five percent of a population
<
Page 9
|
Page 11
>